Stay updated with breaking news from Authorization Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TOKYO, Aug. 18, 2023 /PRNewswire/ -- Astellas Pharma Inc. , today announced the European Medicines Agency has accepted for regulatory review the marketing authorization application for...
Regulatory progress for govorestat for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well as EMA Marketing Authorization Application... -Today at 07:04 am- MarketScreener
Pre-NDA Meeting to be held with FDA this summer to discuss potential NDA submission for govorestat for treatment of Classic Galactosemia EMA Marketing Authorization Application for govorestat for...
STOCKHOLM, June 8, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a marketing authorization application for lecanemab
/PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a marketing authorization application...